Current Activities

• Complete antibody development at UBC’s Biomedical Research Centre
• Commence prototype development
• Patent new discoveries
• File ITA with Health Canada for internal standard developed for use in LC MS MS metabolite detection
• Develop new compound and Mab for new additional substrate
• Develop phase III trial design/markets and indications post pre-trial at SBRC in Manitoba Canada.
• Submit revised protocol to Health Canada
• Seek other detection technologies to reduce costs in the future
• Seek phase III clinical trial centres in Canada and abroad
• Kit placement in test markets
• Accelerate point of care IVD kit post generation of monoclonal antibodies
• Conduct double blinded studies for diagnostic systems are under development
• Expand existing team at BioMark
• Seek development and commercialization partners
• Start and complete lung cancer response to treatment studies at CancerCare Manitoba

BioMark Technologies Summary

BioMark Summary (PDF)  [Right click to download]